Literature DB >> 19031425

Selective antibody precipitation using polyelectrolytes: a novel approach to the purification of monoclonal antibodies.

Paul McDonald1, Corazon Victa, Jayme N Carter-Franklin, Robert Fahrner.   

Abstract

We evaluated the potential for polyelectrolyte induced precipitation of antibodies to replace traditional chromatography purification. We investigated the impact of solution pH, solution ionic strength and polyelectrolyte molecular weight on the degree of precipitation using the anionic polyelectrolytes polyvinylsulfonic acid (PVS), polyacrylic acid (PAA), and polystyrenesulfonic acid (PSS). As we approached the pI of the antibody, charge neutralization of the antibody reduced the antibody-polyelectrolyte interaction, reducing antibody precipitation. At a given pH, increasing solution ionic strength prevented the ionic interaction between the polyelectrolyte and the antibody, reducing antibody precipitation. With increasing pH of precipitation, there was an increase in impurity clearance. Increasing polyelectrolyte molecular weight allowed the precipitation to be performed under conditions of higher ionic strength. PVS was selected as the preferred polyelectrolyte based on step yield following resolubilization, purification performance, as well as the nature of the precipitate. We evaluated PVS precipitation as a replacement for the initial capture step, as well as an intermediate polishing step in the purification of a humanized monoclonal antibody. PVS precipitation separated the antibody from host cell impurities such as host cell proteins (HCP) and DNA, process impurities such as leached protein A, insulin and gentamicin, as well as antibody fragments and aggregates. PVS was subsequently removed from antibody pools to < 1 microg/mg using anion exchange chromatography. PVS precipitation did not impact the biological activity of the resolubilized antibody.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19031425     DOI: 10.1002/bit.22127

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  9 in total

1.  Phase separation of an IgG1 antibody solution under a low ionic strength condition.

Authors:  Hirotaka Nishi; Makoto Miyajima; Hiroaki Nakagami; Masanori Noda; Susumu Uchiyama; Kiichi Fukui
Journal:  Pharm Res       Date:  2010-04-17       Impact factor: 4.200

2.  A purification process for heparin and precursor polysaccharides using the pH responsive behavior of chitosan.

Authors:  Ujjwal Bhaskar; Anne M Hickey; Guoyun Li; Ruchir V Mundra; Fuming Zhang; Li Fu; Chao Cai; Zhimin Ou; Jonathan S Dordick; Robert J Linhardt
Journal:  Biotechnol Prog       Date:  2015-07-16

3.  Poly(vinyl sulfonate) Facilitates bFGF-Induced Cell Proliferation.

Authors:  Thi H Nguyen; Samantha J Paluck; Andrew J McGahran; Heather D Maynard
Journal:  Biomacromolecules       Date:  2015-08-17       Impact factor: 6.988

Review 4.  Evolving trends in mAb production processes.

Authors:  Abhinav A Shukla; Leslie S Wolfe; Sigma S Mostafa; Carnley Norman
Journal:  Bioeng Transl Med       Date:  2017-04-03

5.  Process characterization strategy for a precipitation step for host cell protein reduction.

Authors:  Jessica Prentice; Diemchi Vu; David Robbins; Gisela Ferreira
Journal:  Biotechnol Prog       Date:  2019-10-18

Review 6.  Downstream processing of cell culture-derived virus particles.

Authors:  Michael W Wolf; Udo Reichl
Journal:  Expert Rev Vaccines       Date:  2011-10       Impact factor: 5.217

7.  Overloading ion-exchange membranes as a purification step for monoclonal antibodies.

Authors:  Arick Brown; Jerome Bill; Timothy Tully; Asha Radhamohan; Chris Dowd
Journal:  Biotechnol Appl Biochem       Date:  2010-06-11       Impact factor: 2.431

8.  Scale-down characterization of post-centrifuge flocculation processes for high-throughput process development.

Authors:  Georgina Espuny Garcia Del Real; Jim Davies; Daniel G Bracewell
Journal:  Biotechnol Bioeng       Date:  2014-09-02       Impact factor: 4.530

9.  Optimization of a calcium-dependent Protein A-derived domain for mild antibody purification.

Authors:  Julia Scheffel; Sara Kanje; Jesper Borin; Sophia Hober
Journal:  MAbs       Date:  2019-09-17       Impact factor: 5.857

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.